News

Just 15 per cent of CVD screening budget for assessments

30-Apr-08

Just £25 million may be available for the workforce expected to carry out the cardiovascular disease (CVD) screening programme in England.

Last week health minister Ann Keen said that only 10-15 per cent of the scheme's £250 million annual budget will fund the GPs, pharmacists and health professionals conducting the risk assessments and laboratory tests.

The remaining 85-90 per cent will fund subsequent interventions.  

Ms Keen was responding to questions on the proposals from Conservative shadow health secretary Andrew Lansley.

But GPC negotiator Dr Chaand Nagpaul said: ‘We need to define the workforce and logistical implications first. The funding must follow this modelling.

‘Clearly the proposals will not work unless enabled by adequate resources,' he added. 

‘It needs the support of the workforce that will help implement it.'

Dr John Pittard, a GP in Surrey and member of the  Primary Care Cardiovascular Society (PCCS), said: ‘It doesn't seem very much money to me. Chasing people up and seeing the worried well will eat up a lot of resources.' 

The DoH says the scheme is will take up seven extra appointments a week in each GP practice, but the GPC estimates that the figure could be closer to 40.

tom.ireland@haymarket.com

Comment below and tell us what you think 

Comments

Neil Upton

30/04/2008

Yet more spin. The announced 250 million probably included the compensation for the 10% tax band and a new aircraft carrier

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

nMRCGP exam update - Evidence for aspirin use

Contributed by Dr Louise Newson, a GP in the West Midlands. Read more

RCGP curriculum - Introducing the GP curriculum

Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more

Alcohol problems in young people

Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more

Show all articles

 

Latest Clinical Articles

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Stable angina pectoris

Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more

Show all clinical articles

MIMS Product News

Relistor

New drug - Relistor

Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more

Thalidomide available in the UK

Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more

MMR catch-up programme

The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more

Jobs

 

Job of the Week